Under-the-tongue immunotherapy for dust mite allergies
Part of Ear, nose & throat, Immune system & allergy clinical trials.
This study tests a daily under-the-tongue tablet or drops to reduce allergy symptoms caused by house dust mites. If you have allergic rhinitis and are bothered by dust mites, this treatment might help your nose feel better without needing shots.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 60 years old.
- You must have a doctor's diagnosis of allergic rhinitis (hay fever) for at least 6 months.
- You must have a positive skin prick test for house dust mites (a small bump of at least 5 mm).
- You must have a blood test showing a high level of allergy to dust mites (class 3 or higher).
- Your lung function must be okay (FEV1 at least 70% of predicted).
- You must have noticeable nasal symptoms on most days in the last 2 weeks, and have used allergy medication on at least 5 of those days.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how sublingual immunotherapy tablets, which are placed under the tongue, affect the body's response to dust mite allergies in people with allergic rhinitis. The goal is to understand how these tablets might change the immune system and help improve symptoms.
This study tests a new tablet (Lupatadine Fumarate) for people with nasal allergies caused by dust mites. It looks at how well the medicine works and what it does in the body.
This trial is studying the bacteria in your nose and mouth during treatment with an allergy spray placed under your tongue. The goal is to understand how this treatment affects your allergy symptoms and your body's natural defenses.
This trial tests an under-the-tongue tablet for people with dust mite allergies causing moderate to severe nasal symptoms or mild-to-moderate asthma. The goal is to see if it improves symptoms and can replace or reduce the need for allergy medicines.
This Phase 3 study tests whether dust-mite allergy treatment (likely allergy shots) can reduce allergy symptoms and improve safety. It focuses on people whose nose/eye allergy is triggered by house dust mites and who may also have controlled asthma.
This trial tests a new allergy shot that may reduce symptoms of dust mite allergies, like sneezing, runny nose, and itchy eyes. It might also help with mild asthma caused by dust mites.
Hear when a new Allergic Rhinitis Due to Dust Mite trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.